These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Complex movement behaviour and progression of Huntington's disease. Andrich J, Saft C, Ostholt N, Müller T. Neurosci Lett; 2007 Apr 18; 416(3):272-4. PubMed ID: 17321683 [Abstract] [Full Text] [Related]
4. Cognitive scores in carriers of Huntington's disease gene compared to noncarriers. Foroud T, Siemers E, Kleindorfer D, Bill DJ, Hodes ME, Norton JA, Conneally PM, Christian JC. Ann Neurol; 1995 May 18; 37(5):657-64. PubMed ID: 7755361 [Abstract] [Full Text] [Related]
5. Early cognitive deficits in Swedish gene carriers of Huntington's disease. Robins Wahlin TB, Lundin A, Dear K. Neuropsychology; 2007 Jan 18; 21(1):31-44. PubMed ID: 17201528 [Abstract] [Full Text] [Related]
6. Executive dysfunction in early stages of Huntington's disease is associated with striatal and insular atrophy: a neuropsychological and voxel-based morphometric study. Peinemann A, Schuller S, Pohl C, Jahn T, Weindl A, Kassubek J. J Neurol Sci; 2005 Dec 15; 239(1):11-9. PubMed ID: 16185716 [Abstract] [Full Text] [Related]
7. Prefrontal cortex volume reduction on MRI in preclinical Huntington's disease relates to visuomotor performance and CAG number. Gómez-Ansón B, Alegret M, Muñoz E, Monté GC, Alayrach E, Sánchez A, Boada M, Tolosa E. Parkinsonism Relat Disord; 2009 Mar 15; 15(3):213-9. PubMed ID: 18632301 [Abstract] [Full Text] [Related]
8. Postural deficits in Huntington's disease when performing motor skills involved in daily living. Panzera R, Salomonczyk D, Pirogovosky E, Simmons R, Goldstein J, Corey-Bloom J, Gilbert PE. Gait Posture; 2011 Mar 15; 33(3):457-61. PubMed ID: 21256027 [Abstract] [Full Text] [Related]
9. Cognitive and psychiatric characterization of patients with Huntington's disease and their at-risk relatives. Soliveri P, Monza D, Piacentini S, Paridi D, Nespolo C, Gellera C, Mariotti C, Albanese A, Girotti F. Neurol Sci; 2002 Sep 15; 23 Suppl 2():S105-6. PubMed ID: 12548365 [Abstract] [Full Text] [Related]
10. The relationship between CAG repeat length and clinical progression in Huntington's disease. Ravina B, Romer M, Constantinescu R, Biglan K, Brocht A, Kieburtz K, Shoulson I, McDermott MP. Mov Disord; 2008 Jul 15; 23(9):1223-7. PubMed ID: 18512767 [Abstract] [Full Text] [Related]
11. Caudate nucleus atrophy in Huntington's disease and its relationship with clinical and genetic parameters. Roth J, Klempìi J, Jech R, Zidovská J, Uhrová T, Doubek P, Ulmanová O, Brozová H, Volfová M, Serranová T, Ruzicka E. Funct Neurol; 2005 Jul 15; 20(3):127-30. PubMed ID: 16324236 [Abstract] [Full Text] [Related]
12. Variation of selective gray and white matter atrophy in Huntington's disease. Jech R, Klempír J, Vymazal J, Zidovská J, Klempírová O, Růzicka E, Roth J. Mov Disord; 2007 Sep 15; 22(12):1783-9. PubMed ID: 17579363 [Abstract] [Full Text] [Related]
13. Dorsolateral prefrontal cortex dysfunction in presymptomatic Huntington's disease: evidence from event-related fMRI. Wolf RC, Vasic N, Schönfeldt-Lecuona C, Landwehrmeyer GB, Ecker D. Brain; 2007 Nov 15; 130(Pt 11):2845-57. PubMed ID: 17855375 [Abstract] [Full Text] [Related]
15. Objective assessment of motor slowness in Huntington's disease: clinical correlates and 2-year follow-up. van Vugt JP, Piet KK, Vink LJ, Siesling S, Zwinderman AH, Middelkoop HA, Roos RA. Mov Disord; 2004 Mar 15; 19(3):285-97. PubMed ID: 15022182 [Abstract] [Full Text] [Related]
16. Congruent deterioration of complex and simple movements in patients with Huntington's disease. Saft C, Andrich J, Meisel NM, Przuntek H, Müller T. J Neural Transm Suppl; 2004 Mar 15; (68):97-104. PubMed ID: 15354394 [Abstract] [Full Text] [Related]
17. Proximity to clinical onset influences motor and cognitive performance in presymptomatic Huntington disease gene carriers. Farrow M, Chua P, Churchyard A, Bradshaw JL, Chiu E, Georgiou-Karistianis N. Cogn Behav Neurol; 2006 Dec 15; 19(4):208-16. PubMed ID: 17159618 [Abstract] [Full Text] [Related]
18. Tongue force analysis assesses motor phenotype in premanifest and symptomatic Huntington's disease. Reilmann R, Bohlen S, Klopstock T, Bender A, Weindl A, Saemann P, Auer DP, Ringelstein EB, Lange HW. Mov Disord; 2010 Oct 15; 25(13):2195-202. PubMed ID: 20645403 [Abstract] [Full Text] [Related]
19. MR relaxometry in Huntington's disease: correlation between imaging, genetic and clinical parameters. Vymazal J, Klempír J, Jech R, Zidovská J, Syka M, Růzicka E, Roth J. J Neurol Sci; 2007 Dec 15; 263(1-2):20-5. PubMed ID: 17585943 [Abstract] [Full Text] [Related]
20. Visual function in Huntington's disease patients and presymptomatic gene carriers. O'Donnell BF, Wilt MA, Hake AM, Stout JC, Kirkwood SC, Foroud T. Mov Disord; 2003 Sep 15; 18(9):1027-34. PubMed ID: 14502670 [Abstract] [Full Text] [Related] Page: [Next] [New Search]